跳至主要内容
临床试验/IRCT201411127841N8
IRCT201411127841N8已完成未知

Efficacy of doluxetine add on conventional treatment in in?ammatory bowel disease patients, on depression, anxiety quality of life and severity of symptoms

Isfahan University of Medical Sciences, Psychosomatic Research Center0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • 18-65 years aged; current diagnosis of in?ammatory bowel disease; having no flair up of disease through past six months. Exclusion criteria: any serious medical condition that may interfere with safe study participation; current lactation, pregnancy or inadequate contraception; current serious suicidal intention or plan; lifetime bipolar, psychotic, or obsessive-compulsive disorder; substance use disorders, major depressive disorder or anxiety disorders in the past 6 months; treatment with any psychotropic medication within seven days (or ?ve medication half-lives) of beginning of study.

排除标准

  • 未提供

研究者

发起方
Isfahan University of Medical Sciences, Psychosomatic Research Center

相似试验